|
Volumn 87, Issue 1, 2010, Pages 19-20
|
A piece in the puzzle of personalized medicine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
AMINOTRANSFERASE BLOOD LEVEL;
ATHEROSCLEROSIS;
DRUG INHIBITION;
DRUG MECHANISM;
DRUG SAFETY;
GENETIC VARIABILITY;
HEREDITY;
HUMAN;
HYPERCHOLESTEROLEMIA;
MUSCLE TOXICITY;
NOTE;
PHARMACOGENOMICS;
PRIORITY JOURNAL;
SIDE EFFECT;
SINGLE NUCLEOTIDE POLYMORPHISM;
TOXICITY;
GENETIC VARIATION;
HUMANS;
INDIVIDUALIZED MEDICINE;
PHARMACOGENETICS;
|
EID: 72849129986
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1038/clpt.2009.219 Document Type: Note |
Times cited : (13)
|
References (8)
|